Seeking Alpha

Amarin (AMRN) gets FDA approval of Vascepa, formerly known as AMR101, as an adjunct to diet to...

Amarin (AMRN) gets FDA approval of Vascepa, formerly known as AMR101, as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. Shares are currently halted.
From other sites
Comments (3)
  • brendoo7
    , contributor
    Comments (8) | Send Message
     
    i am so so hapy.and i hope for all the investor who was belive in this drug
    to have avery good business days.
    27 Jul 2012, 07:15 AM Reply Like
  • Stogiees
    , contributor
    Comments (39) | Send Message
     
    Why is AMRN price dropping?
    27 Jul 2012, 10:52 AM Reply Like
  • mitrado
    , contributor
    Comments (2019) | Send Message
     
    Simple... the market's are rigged to force people lose their money.
    This is exactly why I never bought AMRN over $11. Too much risk.
    27 Jul 2012, 12:43 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs